Dolby Laboratories (NYSE:DLB) SVP Sells 7,667 Shares

Dolby Laboratories (NYSE:DLB) SVP John Couling sold 7,667 shares of the firm’s stock in a transaction dated Wednesday, July 1st. The stock was sold at an average price of $53.20, for a total transaction of $407,884.40. Following the completion of the transaction, the senior vice president owned 118,727 shares in the company, valued at approximately $6,316,276.40. The trade was a 6.07% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is available at the SEC website.

Dolby Laboratories Price Performance

Shares of NYSE:DLB traded down $1.12 during trading on Monday, reaching $50.03. 1,305,232 shares of the company’s stock traded hands, compared to its average volume of 802,703. The stock has a market capitalization of $4.73 billion, a P/E ratio of 19.77 and a beta of 0.81. Dolby Laboratories has a 12 month low of $50.03 and a 12 month high of $77.00. The company has a 50 day moving average of $55.29 and a 200-day moving average of $60.61.

Dolby Laboratories (NYSE:DLB) last announced its quarterly earnings results on Thursday, April 30th. The electronics maker reported $1.37 earnings per share for the quarter, topping analysts’ consensus estimates of $1.31 by $0.06. The business had revenue of $395.63 million for the quarter, compared to analysts’ expectations of $385.80 million. Dolby Laboratories had a return on equity of 11.47% and a net margin of 17.85%.The business’s quarterly revenue was up 7.0% on a year-over-year basis. During the same period in the prior year, the firm earned $1.34 EPS. Dolby Laboratories has set its FY 2026 guidance at 4.300-4.450 EPS and its Q3 2026 guidance at 0.560-0.710 EPS. Equities research analysts predict that Dolby Laboratories will post 3.21 earnings per share for the current fiscal year.

Dolby Laboratories Dividend Announcement

The company also recently announced a quarterly dividend, which was paid on Wednesday, May 20th. Shareholders of record on Tuesday, May 12th were paid a dividend of $0.36 per share. This represents a $1.44 dividend on an annualized basis and a yield of 2.9%. The ex-dividend date of this dividend was Tuesday, May 12th. Dolby Laboratories’s payout ratio is presently 56.92%.

Hedge Funds Weigh In On Dolby Laboratories

A number of institutional investors and hedge funds have recently added to or reduced their stakes in the company. Fifth Third Bancorp lifted its holdings in shares of Dolby Laboratories by 34.7% in the fourth quarter. Fifth Third Bancorp now owns 746 shares of the electronics maker’s stock valued at $48,000 after buying an additional 192 shares during the period. Aquatic Capital Management LLC acquired a new position in Dolby Laboratories during the third quarter worth about $56,000. iSAM Funds UK Ltd bought a new stake in Dolby Laboratories in the third quarter worth about $68,000. Hilltop National Bank acquired a new stake in Dolby Laboratories in the 4th quarter valued at about $69,000. Finally, Allworth Financial LP lifted its holdings in Dolby Laboratories by 99.6% in the 3rd quarter. Allworth Financial LP now owns 1,006 shares of the electronics maker’s stock valued at $73,000 after acquiring an additional 502 shares during the last quarter. 58.56% of the stock is owned by institutional investors.

Analysts Set New Price Targets

A number of equities analysts recently issued reports on the company. Weiss Ratings reissued a “hold (c-)” rating on shares of Dolby Laboratories in a report on Wednesday, June 24th. Rosenblatt Securities reaffirmed a “buy” rating and set a $85.00 target price on shares of Dolby Laboratories in a research note on Thursday, June 11th. Wall Street Zen raised Dolby Laboratories from a “hold” rating to a “buy” rating in a research note on Saturday, May 30th. Finally, Barrington Research reissued an “outperform” rating and set a $90.00 price target on shares of Dolby Laboratories in a report on Monday, June 15th. Three equities research analysts have rated the stock with a Buy rating and two have assigned a Hold rating to the stock. According to MarketBeat, Dolby Laboratories presently has an average rating of “Moderate Buy” and an average target price of $90.75.

Dolby Laboratories Company Profile

Dolby Laboratories, Inc is a global leader in audio and imaging technologies, specializing in the development, licensing and deployment of solutions that enhance entertainment and communications experiences. The company’s core business revolves around creating advanced audio codecs, noise reduction systems and spatial sound technologies for a wide range of applications, including cinema, broadcast, gaming, streaming and personal devices. Dolby’s licensing model enables consumer electronics manufacturers, content creators and service providers to integrate its technologies into products such as televisions, smartphones, home theater systems and set-top boxes.

Among its flagship innovations are Dolby Atmos, an immersive audio format that delivers three-dimensional soundscapes for theaters and home systems; Dolby Digital and Dolby Digital Plus, widely adopted audio compression formats for broadcast and streaming; and Dolby Vision, a high-dynamic-range imaging technology that expands color, contrast and brightness in displays.